Inipharm
6 employees on LinkedIn · 4 known investors
Find your way into Inipharm
274 people in our graph share verified history with the Inipharm team — schools, employers, funds. One of them is your warm intro.
Karthik Ardhanareeswaranunlockedknows Chuhan Chung · together at Yale University School of Medicine (overlapped)
×4knows the team · via Texas McCombs School of Business
×2knows the team · via Yale University School of Medicine
knows the team · via Inipharm
knows the team · via Frazier Healthcare Partners
×3knows the team · via Trinity University
Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
Founders & leadership
BF
Brian FarmerinCo-founder · Chief Executive OfficerEntrepreneur-in-Residence at Frazier Life Sciences
HH
Heather Hsu, PhDCo-Founder, Chief Scientific Officer
MG
Michael Gallatin, PhDCo-Founder, SAB Chair
CC
Chuhan ChunginChief Medical OfficerChuhan Chung is a physician-scientist with experience in clinical drug development and translational science; they previously held an academic position as a clinician-scientist with a funded laboratory focused on target validation and translational research.
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ANov 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlap
IQVIA103 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Eli Lilly74 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Bioworld65 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Inipharm for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Inipharm do?
- Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
- Who founded Inipharm?
- Inipharm was founded by Brian Farmer, Heather Hsu, PhD, Michael Gallatin, PhD.
- Who are Inipharm's investors?
- Inipharm's investors include 5AM Ventures, Frazier Life Sciences, Frazier Healthcare Partners, Wu Capital.